Showing 145 to 156 of 171 results
Secondary Breast Cancer: Improved Treatments Offer Hope, but Early Detection Remains Crucial
Two women, Hannah Gardner and Natalie Gibbs, share their experiences with secondary breast cancer, highlighting the often-unclear symptoms, delayed diagnoses, and recent advancements in treatment that are extending survival rates and changing the approach to managing this stage of cancer.
Secondary Breast Cancer: Improved Treatments Offer Hope, but Early Detection Remains Crucial
Two women, Hannah Gardner and Natalie Gibbs, share their experiences with secondary breast cancer, highlighting the often-unclear symptoms, delayed diagnoses, and recent advancements in treatment that are extending survival rates and changing the approach to managing this stage of cancer.
Progress
44% Bias Score
UK's First Liver Transplant for Bowel Cancer Results in Cancer-Free Patient
A 32-year-old woman in Manchester, diagnosed with stage four bowel cancer in 2021, is now cancer-free after undergoing the UK's first liver transplant for this condition, showcasing a new treatment pathway.
UK's First Liver Transplant for Bowel Cancer Results in Cancer-Free Patient
A 32-year-old woman in Manchester, diagnosed with stage four bowel cancer in 2021, is now cancer-free after undergoing the UK's first liver transplant for this condition, showcasing a new treatment pathway.
Progress
36% Bias Score
Groundbreaking Clinical Trials Anticipated in 2025
In 2025, several groundbreaking clinical trials will release preliminary data, including a large-scale US dietary study employing AI analysis (8,000+ adults), Oxford University's CBD trial for psychosis (1,000 patients), and research on personalized cancer vaccines.
Groundbreaking Clinical Trials Anticipated in 2025
In 2025, several groundbreaking clinical trials will release preliminary data, including a large-scale US dietary study employing AI analysis (8,000+ adults), Oxford University's CBD trial for psychosis (1,000 patients), and research on personalized cancer vaccines.
Progress
12% Bias Score
South Korean 'Reverse Therapy' for Cancer: Hype or Hope?
South Korean scientists announced a novel 'reverse therapy' that reportedly transforms cancerous cells into normal ones, but its clinical efficacy needs confirmation, potentially offering a supplementary approach to existing cancer treatments.
South Korean 'Reverse Therapy' for Cancer: Hype or Hope?
South Korean scientists announced a novel 'reverse therapy' that reportedly transforms cancerous cells into normal ones, but its clinical efficacy needs confirmation, potentially offering a supplementary approach to existing cancer treatments.
Progress
52% Bias Score
Medicare Caps Annual Out-of-Pocket Prescription Drug Costs at $2,000
Starting January 1, 2025, Medicare will cap annual out-of-pocket prescription drug costs at $2,000 for its 65 million enrollees, a move expected to significantly aid cancer patients and other older adults facing high medication expenses, particularly those on fixed incomes.
Medicare Caps Annual Out-of-Pocket Prescription Drug Costs at $2,000
Starting January 1, 2025, Medicare will cap annual out-of-pocket prescription drug costs at $2,000 for its 65 million enrollees, a move expected to significantly aid cancer patients and other older adults facing high medication expenses, particularly those on fixed incomes.
Progress
36% Bias Score
Nanoparticle Drug Delivery Boosts Cancer Treatment Effectiveness
Tel Aviv University researchers created nanoparticles delivering two cancer-fighting drugs simultaneously to tumors, increasing effectiveness and reducing side effects; animal tests showed tumors shrank significantly, and mice lived up to three times longer than untreated mice.
Nanoparticle Drug Delivery Boosts Cancer Treatment Effectiveness
Tel Aviv University researchers created nanoparticles delivering two cancer-fighting drugs simultaneously to tumors, increasing effectiveness and reducing side effects; animal tests showed tumors shrank significantly, and mice lived up to three times longer than untreated mice.
Progress
32% Bias Score
J&J's Lung Cancer Drug Extends Life by at Least a Year
Johnson & Johnson announced Tuesday that its two-drug lung cancer regimen, Rybrevant and Lazcluze, extends life expectancy by at least a year compared to AstraZeneca's Tagrisso, based on a pivotal trial, though the regimen has more side effects.
J&J's Lung Cancer Drug Extends Life by at Least a Year
Johnson & Johnson announced Tuesday that its two-drug lung cancer regimen, Rybrevant and Lazcluze, extends life expectancy by at least a year compared to AstraZeneca's Tagrisso, based on a pivotal trial, though the regimen has more side effects.
Progress
60% Bias Score
UK Woman Cancer-Free After Pioneering Liver Transplant
Bianca Perea, a 32-year-old UK resident, became the first patient to successfully receive a liver transplant for advanced bowel cancer that had spread to her liver, resulting in her being declared cancer-free after a multi-year treatment plan.
UK Woman Cancer-Free After Pioneering Liver Transplant
Bianca Perea, a 32-year-old UK resident, became the first patient to successfully receive a liver transplant for advanced bowel cancer that had spread to her liver, resulting in her being declared cancer-free after a multi-year treatment plan.
Progress
40% Bias Score
Cancer Survivor Support Service Improves Quality of Life
The Sheffield Teaching Hospitals NHS Trust's Late Effects Screening Service, established in 2009, provides vital support for long-term cancer survivors, helping them manage treatment side effects and improve their quality of life, as exemplified by 69-year-old Olwen Kramer's experience with non-Hodg...
Cancer Survivor Support Service Improves Quality of Life
The Sheffield Teaching Hospitals NHS Trust's Late Effects Screening Service, established in 2009, provides vital support for long-term cancer survivors, helping them manage treatment side effects and improve their quality of life, as exemplified by 69-year-old Olwen Kramer's experience with non-Hodg...
Progress
52% Bias Score
Animal Dewormer Shows Promise Against Cancer, but Large-Scale Trials Needed
Studies suggest the animal dewormer fenbendazole may shrink tumors in some human cancer patients, but larger clinical trials are needed to confirm its safety and effectiveness, given reports of severe side effects in some cases.
Animal Dewormer Shows Promise Against Cancer, but Large-Scale Trials Needed
Studies suggest the animal dewormer fenbendazole may shrink tumors in some human cancer patients, but larger clinical trials are needed to confirm its safety and effectiveness, given reports of severe side effects in some cases.
Progress
56% Bias Score
King Charles Praises Community Response to UK Riots in Christmas Message
King Charles's annual Christmas message praised the UK's community response to summer riots, emphasizing the repair of damaged buildings, relationships, and trust, while also thanking healthcare professionals for their support during his and his daughter-in-law's cancer treatment.
King Charles Praises Community Response to UK Riots in Christmas Message
King Charles's annual Christmas message praised the UK's community response to summer riots, emphasizing the repair of damaged buildings, relationships, and trust, while also thanking healthcare professionals for their support during his and his daughter-in-law's cancer treatment.
Progress
36% Bias Score
King Charles' Christmas Message to Air from Fitzrovia Chapel
King Charles III will deliver his 2023 Christmas Day message from Fitzrovia Chapel in London, a former hospital chapel with royal links, due to his ongoing cancer treatment; this marks a break from tradition, with the last such event being Queen Elizabeth II's message at Southwark Cathedral in 2006.
King Charles' Christmas Message to Air from Fitzrovia Chapel
King Charles III will deliver his 2023 Christmas Day message from Fitzrovia Chapel in London, a former hospital chapel with royal links, due to his ongoing cancer treatment; this marks a break from tradition, with the last such event being Queen Elizabeth II's message at Southwark Cathedral in 2006.
Progress
28% Bias Score
Showing 145 to 156 of 171 results